Adx-324 — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

1 Recruiting

0 Completed trials

1 Sponsors

11 Countries

Phase III

Phase III: 2

Indications tested

2 total

Extension Study of ADX-324 in Hereditary angioedema Pending

2025-521353-16-00 Phase III 11 countries Adarx Pharmaceuticals Inc.
STOP-HAE: A Phase 3 Study of ADX-324 in HAE Recruiting

2025-521352-38-00 Phase III 11 countries Adarx Pharmaceuticals Inc.

Showing 1–2 of 2 trials